GFAP and neoplasm: The GFAP-CreER driver line allows for widespread and unbiased genetic manipulation in mature astrocytes and progenitor cells from all regions of the central nervous system and has revealed tumor formation in non-proliferative zones such as the cortex, brain stem, cerebellum and spinal cord.